MoonLake Immunotherapeuti Cash Per Share vs. Debt To Equity
| MLTX Stock | USD 53.06 1.76 3.43% |
Cash Per Share | First Reported 2010-12-31 | Previous Quarter 10.4027255 | Current Value 10.92 | Quarterly Volatility 3.68657522 |
For MoonLake Immunotherapeuti profitability analysis, we use financial ratios and fundamental drivers that measure the ability of MoonLake Immunotherapeuti to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well MoonLake Immunotherapeutics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between MoonLake Immunotherapeuti's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of MoonLake Immunotherapeutics over time as well as its relative position and ranking within its peers.
MoonLake |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MoonLake Immunotherapeuti. If investors know MoonLake will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MoonLake Immunotherapeuti listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.27) | Return On Assets (0.13) | Return On Equity (0.17) |
The market value of MoonLake Immunotherapeuti is measured differently than its book value, which is the value of MoonLake that is recorded on the company's balance sheet. Investors also form their own opinion of MoonLake Immunotherapeuti's value that differs from its market value or its book value, called intrinsic value, which is MoonLake Immunotherapeuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MoonLake Immunotherapeuti's market value can be influenced by many factors that don't directly affect MoonLake Immunotherapeuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MoonLake Immunotherapeuti's value and its price as these two are different measures arrived at by different means. Investors typically determine if MoonLake Immunotherapeuti is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MoonLake Immunotherapeuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
MoonLake Immunotherapeuti Debt To Equity vs. Cash Per Share Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining MoonLake Immunotherapeuti's current stock value. Our valuation model uses many indicators to compare MoonLake Immunotherapeuti value to that of its competitors to determine the firm's financial worth. MoonLake Immunotherapeutics is rated below average in cash per share category among its peers. It is rated below average in debt to equity category among its peers . The ratio of Cash Per Share to Debt To Equity for MoonLake Immunotherapeutics is about 418.33 . At this time, MoonLake Immunotherapeuti's Cash Per Share is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the MoonLake Immunotherapeuti's earnings, one of the primary drivers of an investment's value.MoonLake Debt To Equity vs. Cash Per Share
Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
MoonLake Immunotherapeuti |
| = | 2.51 X |
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
MoonLake Immunotherapeuti |
| = | 0.01 % |
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
MoonLake Debt To Equity Comparison
MoonLake Immunotherapeuti is currently under evaluation in debt to equity category among its peers.
MoonLake Immunotherapeuti Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in MoonLake Immunotherapeuti, profitability is also one of the essential criteria for including it into their portfolios because, without profit, MoonLake Immunotherapeuti will eventually generate negative long term returns. The profitability progress is the general direction of MoonLake Immunotherapeuti's change in net profit over the period of time. It can combine multiple indicators of MoonLake Immunotherapeuti, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 2.4 M | 2.5 M | |
| Operating Income | -54.1 M | -51.4 M | |
| Income Before Tax | -44 M | -46.2 M | |
| Total Other Income Expense Net | 10.1 M | 10.6 M | |
| Net Loss | -44.1 M | -46.3 M | |
| Income Tax Expense | 94.4 K | 99.1 K | |
| Net Loss | -52.7 M | -55.3 M | |
| Non Operating Income Net Other | 680.5 K | 340.7 K | |
| Net Loss | -45 M | -42.7 M | |
| Change To Netincome | 11.2 M | 11.7 M | |
| Net Loss | (0.73) | (0.77) | |
| Income Quality | 0.97 | 1.64 | |
| Net Income Per E B T | 0.82 | 1.03 |
MoonLake Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on MoonLake Immunotherapeuti. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of MoonLake Immunotherapeuti position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the MoonLake Immunotherapeuti's important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in MoonLake Immunotherapeuti without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Pair Correlation Now
Pair CorrelationCompare performance and examine fundamental relationship between any two equity instruments |
| All Next | Launch Module |
Use Investing Themes to Complement your MoonLake Immunotherapeuti position
In addition to having MoonLake Immunotherapeuti in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Social Domain Thematic Idea Now
Social Domain
New or established large and mid-sized companies that are involved in the social media industry, including entities that provide web-based or mobile media applications and services across across large segment of population in multiple geographical areas. The Social Domain theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Social Domain Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for MoonLake Stock Analysis
When running MoonLake Immunotherapeuti's price analysis, check to measure MoonLake Immunotherapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MoonLake Immunotherapeuti is operating at the current time. Most of MoonLake Immunotherapeuti's value examination focuses on studying past and present price action to predict the probability of MoonLake Immunotherapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MoonLake Immunotherapeuti's price. Additionally, you may evaluate how the addition of MoonLake Immunotherapeuti to your portfolios can decrease your overall portfolio volatility.